• / Free eNewsletters & Magazine
  • / My Account
Home>Global $200+ Bn Personalized Medicine Market Analysis & Trends to 2025 - Research and Markets

Global $200+ Bn Personalized Medicine Market Analysis & Trends to 2025 - Research and Markets

Global $200+ Bn Personalized Medicine Market Analysis & Trends to 2025 - Research and Markets

10/04/2017

Global $200+ Bn Personalized Medicine Market Analysis & Trends to 2025 - Research and Markets

The "Global Personalized Medicine Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

The Global Personalized Medicine Market is poised to grow at a CAGR of around 9.4% over the next decade to reach approximately $233.4 billion by 2025.

Some of the prominent trends that the market is witnessing include rising use of biomarkers for personalized medicine cancer therapy and rapidly growing new technologies.

Based on Product Type the market is categorized into personalized medicine therapeutics, personalized nutrition & wellness, personalized medicine diagnostics and personalized medical care. Personalized Medicine Therapeutics is further segmented into pharmaceuticals, medical devices and genomic medicine. Personalized Nutrition & Wellness is further divided into complementary medicine, alternative medicine and retail nutrition. Personalized Medicine Diagnostics is further subdivided into esoteric lab services, genetic testing, esoteric lab tests and direct-to-consumer (DTC) diagnostics. Personalized Medical Care is further segmented into health information technology, disease management and telemedicine.

Depending on Therapeutic Area the market is segmented into infectious diseases, cancer management, central nervous system (CNS) disorders, coagulation therapy, blood transfusion safety, autoimmune diseases, diabetes, cardiovascular diseases, neurology, antiviral, oncology and psychiatry. Infectious Diseases is further segmented into Hepatitis B virus (HBV), Human Immunodeficiency Virus (HIV), Hospital Acquired Infections and Hepatitis C virus (HCV). Cancer Management is further divided into blood markers, circulating tumor cells and tissue-based tests

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.

Key Topics Covered:

©2017 Morningstar Advisor. All right reserved.